for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Walgreens Boots Alliance Inc

WBA.O

Latest Trade

46.53USD

Change

1.91(+4.28%)

Volume

12,772,886

Today's Range

44.51

 - 

46.58

52 Week Range

39.03

 - 

57.05

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
44.62
Open
44.86
Volume
12,772,886
3M AVG Volume
125.78
Today's High
46.58
Today's Low
44.51
52 Week High
57.05
52 Week Low
39.03
Shares Out (MIL)
865.61
Market Cap (MIL)
38,623.63
Forward P/E
9.07
Dividend (Yield %)
4.28

Next Event

Q1 2022 Walgreens Boots Alliance Inc Earnings Release

Latest Developments

More

Walgreens Boots Alliance Acquires Remaining Stake In German Gehe-Alliance Healthcare Joint Venture From McKesson

Walgreens And VillageMD Expand In Texas With More Than 20 New Full-Service, Primary Care Practices Opening In Dallas Over The Next Year

Walgreens Boots Alliance Announces Transformational Consumer-Centric Healthcare Strategy To Fuel Long-Term Growth

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Walgreens Boots Alliance Inc

Walgreens Boots Alliance, Inc. is a holding company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of equity method investment in AmerisourceBergen. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots, as well as global health and beauty product brands, including No7, NICE!, Soap & Glory, Liz Earle, Finest Nutrition, Botanics, Well Beginnings, Sleek MakeUP and YourGoodSkin.

Industry

Retail (Drugs)

Contact Info

108 Wilmot Rd

DEERFIELD, IL

60015-5145

United States

+1.847.3152500

http://www.walgreensbootsalliance.com/

Executive Leadership

Stefano Pessina

Executive Chairman of the Board

Rosalind Gates Brewer

Chief Executive Officer, Director

James Kehoe

Global Chief Financial Officer, Executive Vice President

Tracey Brown

Chief Customer Officer, President of Retail Products

Ornella Barra

Chief Operating Officer

Key Stats

3.00 mean rating - 21 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

136.9K

2020

139.5K

2021

132.5K

2022(E)

129.9K
EPS (USD)

2019

5.990

2020

4.740

2021

4.910

2022(E)

4.919
Price To Earnings (TTM)
19.40
Price To Sales (TTM)
0.29
Price To Book (MRQ)
1.65
Price To Cash Flow (TTM)
11.70
Total Debt To Equity (MRQ)
42.66
LT Debt To Equity (MRQ)
36.93
Return on Investment (TTM)
2.25
Return on Equity (TTM)
1.58

Latest News

Latest News

Pharmacy chains defend actions as landmark U.S. opioid trial nears its end

Lawyers for pharmacy chains including CVS and Walgreens on Monday argued they were not to blame for the U.S. opioid epidemic, as jurors prepared to consider whether to hold them responsible for the devastation the drug crisis caused in two Ohio counties.

Walgreens to administer Moderna, J&J COVID-19 booster shots at U.S. stores

Walgreens Boots Alliance Inc said on Friday customers can start receiving booster COVID-19 shots from Moderna Inc and Johnson & Johnson at its U.S. stores.

Alphabet's Wing project unveils new drone delivery model in Texas

Alphabet Inc's Wing said on Wednesday that Walgreens will use its new drones to make deliveries from a store in Texas, in the first use of such vehicles in a major U.S. metro area.

Alphabet's Wing project will unveil new drone delivery model in Texas

Alphabet Inc's Wing drone project said Wednesday that Walgreens will use its new platform to fulfill deliveries at a store in Texas.

Three firms take charge of Walgreens' $5.2 billion VillageMD deal

Three law firms, including Sidley Austin and Latham & Watkins, are guiding Walgreens Boots Alliance Inc’s deal to invest $5.2 billion in VillageMD.

Walgreens to invest over $5.5 billion in health services push

Walgreens Boots Alliance Inc said on Thursday it would take majority stakes in two smaller health care providers for about $5.5 billion, as the second largest U.S. pharmacy chain shifts focus beyond its drugstores.

Walgreens Boots to invest $5.2 billion more in primary care provider VillageMD

Walgreens Boots Alliance Inc will invest an additional $5.2 billion in care provider VillageMD as the pharmacy chain aims to expand primary healthcare services at its stores, the two companies said on Thursday.

Walgreens profit surges 68% on strong pharmacy, retail sales

Walgreens Boots Alliance Inc reported a 68% surge in fourth-quarter profit on Thursday, as it benefited from higher sales at its pharmacy stores in the United States and the United Kingdom.

Walgreens weighing deal to buy Evolent Health - Bloomberg News

Pharmacy chain Walgreens Boots Alliance Inc is considering an acquisition of healthcare IT firm Evolent Health Inc, Bloomberg News reported on Wednesday, citing people familiar with the matter.

UPDATE 1-Walgreens weighing deal to buy Evolent Health - Bloomberg News

Pharmacy chain Walgreens Boots Alliance Inc is considering an acquisition of healthcare IT firm Evolent Health Inc, Bloomberg News reported on Wednesday, citing people familiar with the matter.

Walgreens makes $970 million investment in specialty pharmacy company Shields Health

Walgreens Boots Alliance is spending roughly $970 million to acquire a majority stake in Shields Health Solutions to expand its specialty pharmacy business, the companies said on Tuesday.

Walgreens Boots heaps bonuses, rewards for pharmacists amid labor shortage

Walgreens Boots Alliance Inc will give a one-time bonus of $1,250 to its full-time pharmacists and a $1,000 payment to part-time pharmacists, the drugstore chain said on Friday, as major retailers try to retain people amid intense labor shortage.

Biden to meet executives from Microsoft, Disney on COVID-19 vaccine mandate - WSJ

U.S. President Joe Biden is expected to meet Wednesday with executives from companies including Walt Disney Co, Microsoft Corp and Walgreens Boots Alliance Inc to advance his COVID-19 vaccination requirements for the private sector, the Wall Street Journal reported https...

Walgreens COVID-19 test registration system left patient data unprotected - Recode

Drugstore chain Walgreens Boots Alliance's COVID-19 test registration system exposed data of potentially millions of people, including their phone numbers and email addresses, Recode reported on Monday.

Walgreens to raise minimum hourly wage to $15 for all staff from October

Walgreens Boots Alliance Inc said on Tuesday it would raise the minimum wage of all its staff to $15 an hour from October, as the drugstore chain joins several U.S. firms in trying to retain and lure more people back to work.

Walgreens to raise minimum hourly wage for all team members from Oct

Drugstore chain Walgreens Boots Alliance Inc said on Tuesday it would increase the starting hourly wage for all team members to $15 an hour from October.

Walgreens sees surge in U.S. COVID-19 vaccinations in recent weeks (Aug. 4)

(Corrects paragraph 3 to say Walgreens' previous forecast was for fiscal year 2021, not calendar year 2021 in Aug. 4 story)

CORRECTED-UPDATE 1-Walgreens sees surge in U.S. COVID-19 vaccinations in recent weeks (Aug. 4)

Drugstore chain Walgreens Boots Alliance Inc said on Wednesday it had administered more than 29 million COVID-19 vaccines at its stores so far, led by a surge in parts of the United States that had lagged in vaccinations.

Walgreens expects lower COVID-19 vaccinations in Q4, shares fall

Walgreens Boots Alliance Inc said on Thursday it expects to administer fewer COVID-19 vaccines in the fourth quarter after inoculations peaked in the previous quarter, sending its shares down nearly 7%.

Walgreens lowers full-year COVID-19 vaccination forecast

Walgreens Boots Alliance Inc on Thursday lowered the forecast for COVID-19 vaccine shots to be administered this year, sending shares down nearly 7%.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up